Prescription drug status of obeticholic acid and guidelines for its safe use
Obeticholic acid (Obeticholic acid) is a drug specifically used to treat certain liver diseases and is a farnesoid X receptor (FXR) agonist. By activating FXR, obeticholic acid can regulate the synthesis, secretion and metabolism of bile acids, thereby effectively reducing the accumulation of bile acids in the liver and alleviating liver inflammation and fibrosis.
The drug is primarily used to treat primary biliary cholangitis (PBC), a chronic autoimmune liver disease characterized by progressive damage to the intrahepatic bile ducts, leading to cholestasis and impaired liver function. Obeticholic acid has become an important alternative treatment option for patients with PBC who have an inadequate response to or intolerance to ursodeoxycholic acid (UDCA) therapy. Studies have shown that patients treated with obeticholic acid had significant decreases in liver function indicators such as alkaline phosphatase (ALP) levels, which are critical for assessing disease progression and treatment efficacy.

It needs to be emphasized that obeticholic acid, as a prescription drug, must be used under the guidance of a professional doctor. Due to its powerful pharmacological effects and potential adverse reactions, patients must undergo detailed evaluation and monitoring before use. Common side effects include itching, fatigue, and abdominal pain. Some patients may have severe liver function abnormalities, so liver function tests need to be performed regularly during treatment.
In addition, patients need to closely monitor liver function and undergo regular blood tests when using obeticholic acid to ensure the safety and effectiveness of the drug. This drug may interact with other drugs, especially when used with certain cholesterol-lowering drugs and immunosuppressants. Therefore, patients should strictly follow the doctor's advice and never adjust the dosage or stop taking the medicine on their own.
Reference materials:https://go.drugbank.com/drugs/DB05990
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)